The march forward has become a drunken stumble. I think the result was OK for FY 2015, but it's been sold off on outlook. Reaper.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025